Drug industry needs to 'catch up' with regulatory innovations
This article was originally published in SRA
Executive Summary
Drug regulators are ahead of industry in their thinking in terms of regulatory innovations such as accelerated approval pathways for products and engaging patients in their decision making process and it is industry's job to "catch up", according to Steve Bates, CEO of the UK BioIndustry Association.